The Risk of Diarrhea and Colitis in Patients With Advanced Melanoma Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-AnalysisParul Tandon, Jeffrey D. McCurdy, Scott A. Laurie et al.|Journal of Immunotherapy|2018Cited by 82
453 - The Risk of Diarrhea and Colitis in Patients with Lung Cancer Undergoing Immune-Checkpoint Inhibitor TherapyKirles Bishay, Jeffrey D. McCurdy, Scott A. Laurie et al.|Gastroenterology|2018Cited by 2
P118 THE RISK OF DIARRHEA AND COLITIS IN PATIENTS WITH ADVANCED MELANOMA UNDERGOING IMMUNE-CHECKPOINT INHIBITOR THERAPYParul Tandon, Jeffrey D. McCurdy, Simon Parlow et al.|Gastroenterology|2018Cited by 0
P118 THE RISK OF DIARRHEA AND COLITIS IN PATIENTS WITH ADVANCED MELANOMA UNDERGOING IMMUNE-CHECKPOINT INHIBITOR THERAPYParul Tandon, Jeffrey D. McCurdy, Samuel Bourassa‐Blanchette et al.|Inflammatory Bowel Diseases|2018Cited by 0
Tu1245 - The Risk of Diarrhea and Colitis in Patients with Advanced Melanoma Undergoing Immune-Checkpoint Inhibitor TherapyParul Tandon, Jeffrey D. McCurdy, Samuel Bourassa‐Blanchette et al.|Gastroenterology|2018Cited by 0